@MPGPDX on twitter
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
These filings will just be to get up to date.
I think what is very astute is you realize they have pipeline of news about to break. They went into cash savings mode early 2016 to focus only on FDA clearance. Now that this has happened the wheels are in motion with getting to market, co marketers and for the public fully understanding how medical reimbursements will be a factor in this equation. This is what is going to move this stock forward looking and help us value this patent pending technology of predictive A1C platform
About to bust into 4's again
A few taps on the ask and this will be over .05 today
L2 has really thinned out.
The seller we had this week is gone. Share structure in changed updated 10/25. Even a hint of buying pressure sends this up.
anyone have an email address for McPhearson?
Share Structure as of now
Good Morning. The share structure for 10/25/17 is below.
Authorized: 2,000,000,000
Issued: 242,777,909
Restricted: 152,776,740
Have a good day.
Johnnie
Johnnie Zarecor
Pacific Stock Transfer Company
Direct: 571-485-9999
From the ALRT twitter account
If you build it, they will come. They will most certainly come
From Twitter
They have been sending out tweets referencing all meds in diabetes. The data they collect will be valuable to big Pharma. Anyone who does not think this patent pending product is going to generate huge revunue just does not understand how medical reimbursement work. Revenue will come from multiple streams. They are going to have much bigger players pushing this to a broad adoption sooner than later. That's why they can get this done with the FDA clearance and a staff of consultants. Just look in different geographies who is allowed to prescribe. It's not only Dr's. Absolutely brilliant tool for this disease and they are light years ahead of any comp.
Imagine being able to predict a patient’s current A1c level BEFORE prescribing Actos, or Avandia?
why do you even need to predict it...a blood test will tell you just fine?
An A1c test takes time and money. Plus, it’s a snapshot in time. You need to have an idea where A1c is before you can prescribe./1
Also, many healthcare providers are reimbursed for performance and in diabetes that’s the A1c level./2
If you can control A1c with an accurate dose of insulin you’re performance will improve (as will your and reimbursement)/3
Right now, accurate insulin dosing is difficult. The ALRT algorithm helps. The predictive A1c helps even more/4
Feels like a very big breakout coming. Only a guy feel but think we are very close as word is getting out
News being digested
I think we will continue to see announcements as the building blocks are put into place. They are in the final stage to proof of market then move to widespread adoption into different geographies. The key is what do we value this company at and how do we determine this. Right now you can only read between the lines. My reading says undervalued by 200-500% contingent of a proven marketability of the product. Not the medical device itself but the whole platform where the re occurring revs will be each month by patient.
Correct no Revs but a very viable business forthcoming probably sooner than we think. I guess timeframe is a matter of interpretation however.
All those meds listed will be contacted that they were in. PR. They will be able to see now what data is able to be collected and my guess is they will want this data. Smart move to get Big Pharma looking at what is coming into this space of care
ALRT NEWS
So did Cisco and many others. This is poised to move well Monday and beyond
Exactly GrandeS. It is obvious you have done your homework on this. They have never sold shares. The increase in shares have been for the credit lines but its obvious those shares have not hit the market. Imagine what would happen if Sidney decided to retire some of his shares down the road
I am not bothered by that. They let everyone go last January to use cash to get through clearance. He also has contractors in different time zones. Seems like it was the prudent thing to do to cut cost especially when he has been extending the lines of credit since then and prior to then to fund the company. It is why they own 97.5%. It has been pretty clear nothing is being sold as the SS has not changed since I started checking it with the TA
Wow this is going to be huge.
This video really ties things together and shows the value. Patent pending one of a kind. Look at the efficiency this will bring for medical providers and insurance companies. Not to mention the data that can be collected which would be very valuable and desirable to Pharma on the drugs. Very well thought out platform.
Now that we have seen the platform its a matter of implementation. Adoption by patients and by the medical professional monitoring be that Dr's or Pharmacist will be important. This Benefits insurance companies in a huge way by fixing treatment before it is to late. I believe this will change the game in Diabetes care. Big Pharma will benefit from regular testing resulting in higher sales of products. Patients will get really time feedback and adhere to their care plans. Dr's or Pharmacist get easy to use alerts to manage patients care plans.
Can anyone see any bugs or flaws? I am trying to pick it apart. What would be the downside. It looks very innovative to me even more so after watching the new video
Obviously different laws in different regions apply with who can prescribe and monitor and laws in this regard are also changing quickly. This platform appears to move in the same curve as the laws.
Who will they co market this with? There is a lot of groups/companies that could benefit but what would make the most sense? What is the cost of the platform and how will reimbursements work? Lots of questions now that I have seen the total package. The ALRT strategy is taking shape quickly since Clearance.
I also expect we will see announcements on developments on a more regular basis the closer this gets
Sidney's Response
Simply 50.66% of combined voting power was represented by myself, my wife and one of the contractors. Actually, as I recall, my wife and I have almost 50% of the issued and outstanding shares.
As I have told you that on a fully diluted basis, my wife and I have 97.5% of the fully diluted shares. At the present time, there will be 4.4 billion shares on a fully diluted basis.
----------------------------
My comment. Basically the float is very low. Sidney has all but 2.5% locked up. Any PP would be restricted for a minimum of 6 months if they do it. I suspect he could also continue to fund himself if he does not get what he wants in a PP especially being so close to launch and generating revenue. Literally this is right on the edge of go time next 3-6 months IMO. I don't see Sidney sabatoging his investment. This is a real company that is going to disrupt the market with this innovative approach to chronic diabetes care
I know part of the answer because I actually emailed him last night with questions about the January 2016 filing. Let me do this. I don't want to speak to all this as I am not a expert on this company. I just ask him relevant questions and he responds with things he can answer. I will send the questions/post to Sidney and ask him how he would respond then come back to the board. He answers late last night. I asked him if he ever slept and he laughed. He travels through different time zones frequently and has to be available to contractors in different zones. He said he was on Pacific time today so hopefully will get answers before end of day
Update: Message is sent Sidney.
It corrected back up on virtually no volume as well. Did you notice that or did I imagine that. I was busy but that is what it appeared. I just think someone wanted to exit and the MM's have all the leverage to fleece with super low volume. They made some pay to get out
I don't know how accurate they are on share structure. I just know Sidney and his wife own 97.5% if the issued. TA is not gagged and johnnie will send you updates number with an email if asked. I have not sent for an update as nothing has changed the first two times and nothing in the trading makes me think anything would have
Ok that makes total sense. Stuff runs and I would not be surprised if someone sold at a loss to jump into that dog before the mysterious scam comment was unleashed.
This is going to be a volatile one but we are pretty much sitting at bottom. You can't get much under .015. It will move fast with the slightest pressure
Wolf what are you talking about. Not following what your saying.
This deal will close. Tiny float any selling will drop it but it will go up 5 times as fast with buying pressure or follow up filing
Thanks ONCO I can't reply to PVT
I think in the next 3-4 months there will be a steady flow of news. How it will impact things I don't know but I suspect at this stage heading toward a commercial rollout it is going to be a nice ride. I think everyone is waiting to see what this CEO has up his sleeve to get this platform to market. These guys are subject matter experts and have developed something that is a disruptive change to care for diabetics. The changes in the law regarding tech and who can prescribe medicine is a big part of this platform. How medical reimburments works all fit with this technology as well. If anyone is familiar with how reimbursements work in Canada and US I would love to learn more about it because it's a factor in all this. They have been talking about it for 3 years in videos. Everything these days is about being efficient and keeping cost down. This seems like a perfectly developed technology to benefit the patient, insurer and Professional prescribing and monitoring the patient. The patient benefits by uploading real time data so treatment stays on course. Insurers benift from lower cost for chronic care. Pharma benefits by patient actually testing regularly so more product is sold.
Any Dr's, Pharmacist or medical professionals on the board? If so what do you see in this?
Opinions on this spread as we wait?
Almost feels like a artificial halt at this level to discourage trading. Would be very counter intuitive for a MM but maybe they know what is coming
I have spent all night watching everything on ALRT. If you are serious about learning this technology and how it is going to generate revenue I would take the time to watch all the way back to 2014. There is some great DD that is relevant today
https://m.youtube.com/user/ALRTechnologies
This video below is 3 years old and Bill Smith no longer with the company as near as I can tell. Listen to the early stages of this idea of the platform. Listen closely to the end about reimbursements. The FDA clearance on the re vamped system came from these early stage ideas. Everything is coming together. Even though it was theee years ago how often do you see a OTC on opening bell?
http://video.foxbusiness.com/v/3711882462001/?#sp=show-clips
This is going to be absolutely huge
Medical supplies. Software. Patient adherence. Reimbursement system. Remote chronic care. It helps big pharma sell product with consistent testing and more use of product. Helps insurers manage patients before cost rise due to non adherence. It allows patient monitoring by the caregiver, Dr or Pharmacist were allowed. They have the studies and data to back it up. They already have a good industry reputation. They have the leading edge product ready to roll out. They have patents pending. I can see why Sidney is looking for investors and not loan sharks. I don't think the path to very large revenues is far off. Time to start thinking about who will co market or partner with ALRT as it seems inevitable at this point that it will happen.
This is going to be huge! I cant believe it is so so quiet.
I suspect Spectrum King is carrying debt that will be coming to the party but that is normal for the growth phase they are in.
Lets get this party started already
Nothing in the share structure changed during the run or after but I have not checked in about 2 weeks
From my conversation I don't think he is looking to make money off his stock as far as selling any right now. I suppose if you put 20 million in you're probably not hurting anyway. Maybe his plan is to get this rolling then sell? I think he thinks the market is huge though and once it's tapped into his market cap will ascend with recurring revs anyway. I don't really know what he is thinking that far down the road. All I know from what he said is he knows the value of what he developed. I think as we get more news we will figure out how big this is as far as total available market. Of course it will take time to penetrate different geographies I am sure
He has 16 full time on contract and 2 part time I think he said
20 Million invested and 97.5 percent ownership. This is why the stock moves.
Any private placement will be restricted. He wants investors that see the value with deep pockets. We are just along for the ride but a decent market cap would be helpful
I personally think to much has gone into this for the CEO not to just blow us away over the next 6 months. I think this is a stock that is very quietly going to stair step up and one day people will just say WTF I should have held back then when I had a million plus shares from first run.
Can't wait for the company to announce more developments. The best part is the CEO does not hold expectations about news he just releases when appropriate. He is a cool guy with a passion and I get the feeling works his ass off
Once they announce commercial partners and co-marketers that are big name companies the market will begin to see more clearly the potential value of this
Brilliant
I really doubt he has put his last 5-7 years developement this to get to this stage without a solid marketing plan. I have to believe he knows the value of what he has and how to get the value from the market. Any barriers to entry are erased with the right partner.
This is way undervalued based on the stage the company is in. It's not worth a dollar yet but it's worth a heck of a lot more than 4-5 cents.
That is what I thought as well. Does anyone know how it works in Canada with Pharmacist? I know different geographies will have different laws.
This is really a medical supply play coupled with a tech play when the whole platform is tied together into a system. The tech side is diagnostics, data transfer and calculations that only ALRT has the data to produce. The medical supply side just is the avenue to get to the data. Boiling it down to data is the key. Really there are a lot of moving parts to how this will all roll out and what the strategy will be
I just found this and it is very interesting
California passed a similar law that took effect in April 2016 and declares pharmacists to be health care providers. The law further expands pharmacists’ scope of practice by not only allowing them to prescribe hormonal contraceptives to any age group, but also permitting them to use their skills in many more ways.
Under California’s law, pharmacists are able to initiate certain prescriptions, as well as provide clinical advice to their patients. Other provisions permit pharmacists to:
· Prescribe nicotine replacement therapy, which normally requires a prescription from a physician.
· Prescribe medications for travel health purposes, such as scopolamine patches and promethazine.
· Mandate tests to monitor and maintain the efficacy and toxicity of drug therapies for patients with comorbidities, such as diabetes, hypertension, and hyperlipidemia.
http://www.pharmacytimes.com/contributor/shelby-leheny-pharmd-candidate-2017/2016/05/could-prescribing-become-a-daily-duty-for-pharmacists
This is older but has some good info from one of their early white papers
http://care.diabetesjournals.org/content/33/8/1738
I am excited to see what transpires here. Not a short term flip for me. I believe this is going to take a bit of time to fully develop. The technology contrary to what one would say here is disruptive. FDA clearance, inventor invested heavily and funds company, getting current. I think to fully understand this play you need to understand how it benefits the patient, prescriber and insurance companies.